Fulgent Genetics (FLGT) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US3596641098

Fulgent Genetics, Inc. and its subsidiaries offer a wide range of clinical diagnostic and therapeutic solutions both in the United States and internationally, catering to physicians and patients. Their services encompass molecular and genetic testing, anatomic pathology tests like gastrointestinal, dermatopathology, urologic pathology, and oncology tests. They also provide next-generation sequencer services covering hereditary cancer, cardiovascular genetics, reproductive health, and neurodegenerative genetics.

Moreover, Fulgent Genetics focuses on therapeutic development by creating drug candidates to treat various cancers. They employ a unique nanoencapsulation and targeted therapy platform aimed at improving the effectiveness and safety profiles of cancer medications. The company also manages a picture genetics platform featuring exclusive gene probes, advanced data analytical tools, and laboratory information management systems to help individuals discover health indicators in their DNA.

Their clientele includes insurance companies, hospitals, medical institutions, laboratories, government entities, payors, municipalities, corporations, and individuals seeking their services. Initially known as Fulgent Diagnostics, the company rebranded as Fulgent Genetics in August 2016, having been established in 2011 with its headquarters situated in Temple City, California. For more information, visit their website: https://www.fulgentgenetics.com

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Fulgent Genetics (FLGT) - Stock Price & Dividends

FLGT Stock Overview

Market Cap in USD 613m
Sector Healthcare
Industry Diagnostics & Research
GiC SubIndustry Health Care Services
TER 0.00%
IPO / Inception 2016-09-29

FLGT Stock Ratings

Growth 5y 1.76
Fundamental -51.9
Dividend -
Rel. Performance vs Sector -4.09
Analysts 3.33/5
Fair Price Momentum 18.52 USD
Fair Price DCF 3.88 USD

FLGT Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

FLGT Growth Ratios

Growth 12m -25.53%
Growth Correlation 12m -72%
Growth Correlation 3m -82%
CAGR 5y 26.07%
Sharpe Ratio 12m -0.73
Alpha vs SP500 12m -58.13
Beta vs SP500 5y weekly 1.29
ValueRay RSI 70.06
Volatility GJR Garch 1y 38.30%
Price / SMA 50 -2.88%
Price / SMA 200 -21.83%
Current Volume 164k
Average Volume 20d 163.3k

External Links for FLGT Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
X (Twitter)Stocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of FLGT stocks?
As of May 03, 2024, the stock is trading at USD 21.24 with a total of 164,024 shares traded.
Over the past week, the price has changed by +6.04%, over one month by -0.14%, over three months by -13.83% and over the past year by -26.93%.
What is the forecast for FLGT stock price target?
According to ValueRays Forecast Model, FLGT Fulgent Genetics will be worth about 20.8 in May 2025. The stock is currently trading at 21.24. This means that the stock has a potential downside of -1.98%.
Issuer Forecast Upside
Wallstreet Target Price 26.7 25.6
Analysts Target Price 36.5 71.8
ValueRay Target Price 20.8 -1.98